BioCentury
ARTICLE | Clinical News

Boceprevir: Additional Phase II data

November 9, 2009 8:00 AM UTC

Additional data from the international Phase II SPRINT-1 trial showed that of 50 patients who did not respond to PegIntron peginterferon alfa-2b and Rebetol ribavirin at week 4, defined as <1 log de...